Kellerhals Carrard advises Alp Bio on $2.2M funding round

Kellerhals Carrard advised Swiss biotech startup Alp Bio throughout closing of a USD 2.2 million pre-seed funding round. The round was led by Munich-based venture capital firm 42CAP, with additional participation from Venture Kick and a group of strategic angel investors.

Deal details

Alp Bio AG was founded by Christian Vahlensieck, Lucas Schaus, , Anatol Ehrlich and Punit Mehra. The company develops an organoid platform aimed at serving pharmaceutical and biotech clients. The proceeds from the pre-seed round will be directed toward scaling the organoid platform, launching early partner projects with pharma and biotech teams, and expanding the company’s workforce across Switzerland and the United States.

The Kellerhals Carrard team 

Kellerhals Carrard’s corporate/VC team included partners Dario Silberschmidt (pictured left) and Luana Stämpfli (pictured right), supported by legal advisor Klara Sophie Weismann and paralegal Lisa Schmid.